nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—ADRA2C—Brimonidine—glaucoma	0.135	0.171	CbGbCtD
Lurasidone—ADRA2C—Apraclonidine—glaucoma	0.135	0.171	CbGbCtD
Lurasidone—ADRA2C—Dipivefrin—glaucoma	0.108	0.137	CbGbCtD
Lurasidone—ADRA2A—Apraclonidine—glaucoma	0.0893	0.113	CbGbCtD
Lurasidone—ADRA2A—Brimonidine—glaucoma	0.0893	0.113	CbGbCtD
Lurasidone—ADRA2A—Dipivefrin—glaucoma	0.0714	0.0903	CbGbCtD
Lurasidone—ADRA2C—Clonidine—glaucoma	0.0562	0.0711	CbGbCtD
Lurasidone—ADRA2A—Clonidine—glaucoma	0.0371	0.0469	CbGbCtD
Lurasidone—CYP3A4—Pilocarpine—glaucoma	0.0161	0.0203	CbGbCtD
Lurasidone—CYP3A4—Brinzolamide—glaucoma	0.0126	0.0159	CbGbCtD
Lurasidone—CYP3A4—Dorzolamide—glaucoma	0.0122	0.0154	CbGbCtD
Lurasidone—CYP3A4—Methazolamide—glaucoma	0.0108	0.0137	CbGbCtD
Lurasidone—CYP3A4—Acetazolamide—glaucoma	0.00867	0.011	CbGbCtD
Lurasidone—CYP3A4—Clonidine—glaucoma	0.00784	0.00992	CbGbCtD
Lurasidone—Hypotension—Brimonidine—glaucoma	0.00025	0.00127	CcSEcCtD
Lurasidone—Nausea—Levobunolol—glaucoma	0.00025	0.00126	CcSEcCtD
Lurasidone—Infection—Brinzolamide—glaucoma	0.00025	0.00126	CcSEcCtD
Lurasidone—Nervous system disorder—Travoprost—glaucoma	0.00025	0.00126	CcSEcCtD
Lurasidone—Nasopharyngitis—Timolol—glaucoma	0.00025	0.00126	CcSEcCtD
Lurasidone—Tachycardia—Travoprost—glaucoma	0.000249	0.00126	CcSEcCtD
Lurasidone—Somnolence—Acetazolamide—glaucoma	0.000248	0.00126	CcSEcCtD
Lurasidone—Skin disorder—Travoprost—glaucoma	0.000247	0.00125	CcSEcCtD
Lurasidone—Hyperhidrosis—Dorzolamide—glaucoma	0.000247	0.00125	CcSEcCtD
Lurasidone—Abdominal pain—Apraclonidine—glaucoma	0.000247	0.00125	CcSEcCtD
Lurasidone—Nervous system disorder—Brinzolamide—glaucoma	0.000247	0.00125	CcSEcCtD
Lurasidone—Angiopathy—Clonidine—glaucoma	0.000246	0.00125	CcSEcCtD
Lurasidone—Rash—Latanoprost—glaucoma	0.000246	0.00124	CcSEcCtD
Lurasidone—Agranulocytosis—Betaxolol—glaucoma	0.000246	0.00124	CcSEcCtD
Lurasidone—Dermatitis—Latanoprost—glaucoma	0.000246	0.00124	CcSEcCtD
Lurasidone—Dyspepsia—Acetazolamide—glaucoma	0.000246	0.00124	CcSEcCtD
Lurasidone—Tachycardia—Brinzolamide—glaucoma	0.000245	0.00124	CcSEcCtD
Lurasidone—Skin disorder—Brinzolamide—glaucoma	0.000244	0.00124	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000244	0.00123	CcSEcCtD
Lurasidone—Arrhythmia—Clonidine—glaucoma	0.000243	0.00123	CcSEcCtD
Lurasidone—Decreased appetite—Acetazolamide—glaucoma	0.000243	0.00123	CcSEcCtD
Lurasidone—Insomnia—Brimonidine—glaucoma	0.000242	0.00123	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000241	0.00122	CcSEcCtD
Lurasidone—Bradycardia—Betaxolol—glaucoma	0.000241	0.00122	CcSEcCtD
Lurasidone—Fatigue—Acetazolamide—glaucoma	0.000241	0.00122	CcSEcCtD
Lurasidone—Infection—Pilocarpine—glaucoma	0.00024	0.00121	CcSEcCtD
Lurasidone—Nausea—Methazolamide—glaucoma	0.000239	0.00121	CcSEcCtD
Lurasidone—Hypotension—Dorzolamide—glaucoma	0.000239	0.00121	CcSEcCtD
Lurasidone—Dyspnoea—Brimonidine—glaucoma	0.000239	0.00121	CcSEcCtD
Lurasidone—Somnolence—Brimonidine—glaucoma	0.000238	0.0012	CcSEcCtD
Lurasidone—Mental disorder—Clonidine—glaucoma	0.000238	0.0012	CcSEcCtD
Lurasidone—Hypotension—Travoprost—glaucoma	0.000238	0.0012	CcSEcCtD
Lurasidone—Shock—Pilocarpine—glaucoma	0.000238	0.0012	CcSEcCtD
Lurasidone—Tachycardia—Pilocarpine—glaucoma	0.000236	0.00119	CcSEcCtD
Lurasidone—Dyspepsia—Brimonidine—glaucoma	0.000236	0.00119	CcSEcCtD
Lurasidone—Angina pectoris—Timolol—glaucoma	0.000235	0.00119	CcSEcCtD
Lurasidone—Hypotension—Brinzolamide—glaucoma	0.000235	0.00119	CcSEcCtD
Lurasidone—Hyperhidrosis—Pilocarpine—glaucoma	0.000234	0.00118	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000233	0.00118	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Travoprost—glaucoma	0.000232	0.00117	CcSEcCtD
Lurasidone—Insomnia—Dorzolamide—glaucoma	0.000231	0.00117	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Brimonidine—glaucoma	0.000231	0.00117	CcSEcCtD
Lurasidone—Fatigue—Brimonidine—glaucoma	0.000231	0.00117	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000229	0.00116	CcSEcCtD
Lurasidone—Dyspnoea—Dorzolamide—glaucoma	0.000228	0.00115	CcSEcCtD
Lurasidone—Insomnia—Brinzolamide—glaucoma	0.000227	0.00115	CcSEcCtD
Lurasidone—Somnolence—Dorzolamide—glaucoma	0.000227	0.00115	CcSEcCtD
Lurasidone—Muscle spasms—Clonidine—glaucoma	0.000227	0.00115	CcSEcCtD
Lurasidone—Dyspnoea—Travoprost—glaucoma	0.000227	0.00115	CcSEcCtD
Lurasidone—Hypotension—Pilocarpine—glaucoma	0.000226	0.00114	CcSEcCtD
Lurasidone—Dysuria—Timolol—glaucoma	0.000226	0.00114	CcSEcCtD
Lurasidone—Dyspepsia—Dorzolamide—glaucoma	0.000225	0.00114	CcSEcCtD
Lurasidone—Dyspnoea—Brinzolamide—glaucoma	0.000224	0.00113	CcSEcCtD
Lurasidone—Dyspepsia—Travoprost—glaucoma	0.000224	0.00113	CcSEcCtD
Lurasidone—Asthenia—Apraclonidine—glaucoma	0.000224	0.00113	CcSEcCtD
Lurasidone—Somnolence—Brinzolamide—glaucoma	0.000224	0.00113	CcSEcCtD
Lurasidone—Vision blurred—Clonidine—glaucoma	0.000223	0.00113	CcSEcCtD
Lurasidone—Decreased appetite—Dorzolamide—glaucoma	0.000222	0.00112	CcSEcCtD
Lurasidone—Erectile dysfunction—Timolol—glaucoma	0.000222	0.00112	CcSEcCtD
Lurasidone—Tremor—Clonidine—glaucoma	0.000222	0.00112	CcSEcCtD
Lurasidone—Dyspepsia—Brinzolamide—glaucoma	0.000221	0.00112	CcSEcCtD
Lurasidone—Eye disorder—Betaxolol—glaucoma	0.000221	0.00112	CcSEcCtD
Lurasidone—Pruritus—Apraclonidine—glaucoma	0.000221	0.00112	CcSEcCtD
Lurasidone—Fatigue—Dorzolamide—glaucoma	0.000221	0.00112	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00022	0.00111	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Travoprost—glaucoma	0.00022	0.00111	CcSEcCtD
Lurasidone—Fatigue—Travoprost—glaucoma	0.00022	0.00111	CcSEcCtD
Lurasidone—Cardiac disorder—Betaxolol—glaucoma	0.00022	0.00111	CcSEcCtD
Lurasidone—Insomnia—Pilocarpine—glaucoma	0.000219	0.00111	CcSEcCtD
Lurasidone—Decreased appetite—Brinzolamide—glaucoma	0.000219	0.00111	CcSEcCtD
Lurasidone—Hyperglycaemia—Timolol—glaucoma	0.000218	0.0011	CcSEcCtD
Lurasidone—Agitation—Clonidine—glaucoma	0.000217	0.0011	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000217	0.0011	CcSEcCtD
Lurasidone—Asthenia—Bimatoprost—glaucoma	0.000217	0.0011	CcSEcCtD
Lurasidone—Fatigue—Brinzolamide—glaucoma	0.000217	0.0011	CcSEcCtD
Lurasidone—Angioedema—Clonidine—glaucoma	0.000216	0.00109	CcSEcCtD
Lurasidone—Dyspnoea—Pilocarpine—glaucoma	0.000215	0.00109	CcSEcCtD
Lurasidone—Somnolence—Pilocarpine—glaucoma	0.000215	0.00109	CcSEcCtD
Lurasidone—Angiopathy—Betaxolol—glaucoma	0.000215	0.00109	CcSEcCtD
Lurasidone—Pruritus—Bimatoprost—glaucoma	0.000214	0.00108	CcSEcCtD
Lurasidone—Diarrhoea—Apraclonidine—glaucoma	0.000213	0.00108	CcSEcCtD
Lurasidone—Malaise—Clonidine—glaucoma	0.000213	0.00108	CcSEcCtD
Lurasidone—Dyspepsia—Pilocarpine—glaucoma	0.000213	0.00108	CcSEcCtD
Lurasidone—Syncope—Clonidine—glaucoma	0.000212	0.00107	CcSEcCtD
Lurasidone—Arrhythmia—Betaxolol—glaucoma	0.000211	0.00107	CcSEcCtD
Lurasidone—Decreased appetite—Pilocarpine—glaucoma	0.00021	0.00106	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dorzolamide—glaucoma	0.000209	0.00106	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000209	0.00106	CcSEcCtD
Lurasidone—Gastrointestinal pain—Travoprost—glaucoma	0.000208	0.00105	CcSEcCtD
Lurasidone—Loss of consciousness—Clonidine—glaucoma	0.000208	0.00105	CcSEcCtD
Lurasidone—Mental disorder—Betaxolol—glaucoma	0.000207	0.00105	CcSEcCtD
Lurasidone—Dizziness—Apraclonidine—glaucoma	0.000206	0.00104	CcSEcCtD
Lurasidone—Malnutrition—Betaxolol—glaucoma	0.000206	0.00104	CcSEcCtD
Lurasidone—Abdominal pain—Dorzolamide—glaucoma	0.000202	0.00102	CcSEcCtD
Lurasidone—Abdominal pain—Travoprost—glaucoma	0.000201	0.00102	CcSEcCtD
Lurasidone—Agranulocytosis—Timolol—glaucoma	0.000201	0.00102	CcSEcCtD
Lurasidone—Anxiety—Clonidine—glaucoma	0.000201	0.00102	CcSEcCtD
Lurasidone—Asthenia—Acetazolamide—glaucoma	0.0002	0.00101	CcSEcCtD
Lurasidone—Dizziness—Bimatoprost—glaucoma	0.0002	0.00101	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.0002	0.00101	CcSEcCtD
Lurasidone—Vomiting—Apraclonidine—glaucoma	0.000198	0.001	CcSEcCtD
Lurasidone—Muscle spasms—Betaxolol—glaucoma	0.000198	0.001	CcSEcCtD
Lurasidone—Gastrointestinal pain—Pilocarpine—glaucoma	0.000198	0.001	CcSEcCtD
Lurasidone—Dry mouth—Clonidine—glaucoma	0.000197	0.000996	CcSEcCtD
Lurasidone—Bradycardia—Timolol—glaucoma	0.000197	0.000995	CcSEcCtD
Lurasidone—Dermatitis—Apraclonidine—glaucoma	0.000197	0.000994	CcSEcCtD
Lurasidone—Vision blurred—Betaxolol—glaucoma	0.000194	0.000982	CcSEcCtD
Lurasidone—Tremor—Betaxolol—glaucoma	0.000193	0.000976	CcSEcCtD
Lurasidone—Asthenia—Brimonidine—glaucoma	0.000192	0.000972	CcSEcCtD
Lurasidone—Infection—Clonidine—glaucoma	0.000192	0.00097	CcSEcCtD
Lurasidone—Abdominal pain—Pilocarpine—glaucoma	0.000191	0.000967	CcSEcCtD
Lurasidone—Diarrhoea—Acetazolamide—glaucoma	0.000191	0.000966	CcSEcCtD
Lurasidone—Rash—Bimatoprost—glaucoma	0.000191	0.000965	CcSEcCtD
Lurasidone—Dermatitis—Bimatoprost—glaucoma	0.000191	0.000964	CcSEcCtD
Lurasidone—Anaemia—Betaxolol—glaucoma	0.00019	0.000963	CcSEcCtD
Lurasidone—Shock—Clonidine—glaucoma	0.00019	0.000961	CcSEcCtD
Lurasidone—Connective tissue disorder—Timolol—glaucoma	0.00019	0.000961	CcSEcCtD
Lurasidone—Pruritus—Brimonidine—glaucoma	0.000189	0.000959	CcSEcCtD
Lurasidone—Nervous system disorder—Clonidine—glaucoma	0.000189	0.000958	CcSEcCtD
Lurasidone—Tachycardia—Clonidine—glaucoma	0.000188	0.000953	CcSEcCtD
Lurasidone—Skin disorder—Clonidine—glaucoma	0.000187	0.000948	CcSEcCtD
Lurasidone—Hyperhidrosis—Clonidine—glaucoma	0.000187	0.000944	CcSEcCtD
Lurasidone—Malaise—Betaxolol—glaucoma	0.000186	0.000939	CcSEcCtD
Lurasidone—Nausea—Apraclonidine—glaucoma	0.000185	0.000937	CcSEcCtD
Lurasidone—Vertigo—Betaxolol—glaucoma	0.000185	0.000936	CcSEcCtD
Lurasidone—Syncope—Betaxolol—glaucoma	0.000185	0.000934	CcSEcCtD
Lurasidone—Dizziness—Acetazolamide—glaucoma	0.000185	0.000934	CcSEcCtD
Lurasidone—Asthenia—Dorzolamide—glaucoma	0.000184	0.000928	CcSEcCtD
Lurasidone—Asthenia—Travoprost—glaucoma	0.000183	0.000924	CcSEcCtD
Lurasidone—Pruritus—Dorzolamide—glaucoma	0.000181	0.000915	CcSEcCtD
Lurasidone—Loss of consciousness—Betaxolol—glaucoma	0.000181	0.000915	CcSEcCtD
Lurasidone—Eye disorder—Timolol—glaucoma	0.000181	0.000913	CcSEcCtD
Lurasidone—Asthenia—Brinzolamide—glaucoma	0.00018	0.000913	CcSEcCtD
Lurasidone—Hypotension—Clonidine—glaucoma	0.00018	0.000912	CcSEcCtD
Lurasidone—Pruritus—Travoprost—glaucoma	0.00018	0.000912	CcSEcCtD
Lurasidone—Nausea—Bimatoprost—glaucoma	0.00018	0.000909	CcSEcCtD
Lurasidone—Cardiac disorder—Timolol—glaucoma	0.000179	0.000907	CcSEcCtD
Lurasidone—Pruritus—Brinzolamide—glaucoma	0.000178	0.0009	CcSEcCtD
Lurasidone—Vomiting—Acetazolamide—glaucoma	0.000177	0.000898	CcSEcCtD
Lurasidone—Dizziness—Brimonidine—glaucoma	0.000177	0.000896	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Clonidine—glaucoma	0.000176	0.00089	CcSEcCtD
Lurasidone—Angiopathy—Timolol—glaucoma	0.000175	0.000887	CcSEcCtD
Lurasidone—Myalgia—Betaxolol—glaucoma	0.000175	0.000887	CcSEcCtD
Lurasidone—Diarrhoea—Dorzolamide—glaucoma	0.000175	0.000885	CcSEcCtD
Lurasidone—Anxiety—Betaxolol—glaucoma	0.000175	0.000884	CcSEcCtD
Lurasidone—Insomnia—Clonidine—glaucoma	0.000175	0.000883	CcSEcCtD
Lurasidone—Diarrhoea—Travoprost—glaucoma	0.000174	0.000882	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000174	0.000881	CcSEcCtD
Lurasidone—Asthenia—Pilocarpine—glaucoma	0.000173	0.000877	CcSEcCtD
Lurasidone—Arrhythmia—Timolol—glaucoma	0.000173	0.000873	CcSEcCtD
Lurasidone—Dyspnoea—Clonidine—glaucoma	0.000172	0.000871	CcSEcCtD
Lurasidone—Diarrhoea—Brinzolamide—glaucoma	0.000172	0.00087	CcSEcCtD
Lurasidone—Somnolence—Clonidine—glaucoma	0.000172	0.000868	CcSEcCtD
Lurasidone—Dry mouth—Betaxolol—glaucoma	0.000171	0.000867	CcSEcCtD
Lurasidone—Pruritus—Pilocarpine—glaucoma	0.000171	0.000865	CcSEcCtD
Lurasidone—Mental disorder—Timolol—glaucoma	0.000169	0.000856	CcSEcCtD
Lurasidone—Dizziness—Dorzolamide—glaucoma	0.000169	0.000856	CcSEcCtD
Lurasidone—Rash—Brimonidine—glaucoma	0.000169	0.000854	CcSEcCtD
Lurasidone—Dermatitis—Brimonidine—glaucoma	0.000169	0.000854	CcSEcCtD
Lurasidone—Dizziness—Travoprost—glaucoma	0.000168	0.000852	CcSEcCtD
Lurasidone—Malnutrition—Timolol—glaucoma	0.000168	0.000851	CcSEcCtD
Lurasidone—Decreased appetite—Clonidine—glaucoma	0.000168	0.000849	CcSEcCtD
Lurasidone—Infection—Betaxolol—glaucoma	0.000167	0.000845	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Clonidine—glaucoma	0.000167	0.000843	CcSEcCtD
Lurasidone—Fatigue—Clonidine—glaucoma	0.000166	0.000842	CcSEcCtD
Lurasidone—Dizziness—Brinzolamide—glaucoma	0.000166	0.000841	CcSEcCtD
Lurasidone—Nausea—Acetazolamide—glaucoma	0.000166	0.000839	CcSEcCtD
Lurasidone—Diarrhoea—Pilocarpine—glaucoma	0.000165	0.000837	CcSEcCtD
Lurasidone—Shock—Betaxolol—glaucoma	0.000165	0.000836	CcSEcCtD
Lurasidone—Nervous system disorder—Betaxolol—glaucoma	0.000165	0.000834	CcSEcCtD
Lurasidone—Tachycardia—Betaxolol—glaucoma	0.000164	0.00083	CcSEcCtD
Lurasidone—Skin disorder—Betaxolol—glaucoma	0.000163	0.000826	CcSEcCtD
Lurasidone—Vomiting—Dorzolamide—glaucoma	0.000163	0.000823	CcSEcCtD
Lurasidone—Hyperhidrosis—Betaxolol—glaucoma	0.000162	0.000822	CcSEcCtD
Lurasidone—Rash—Dorzolamide—glaucoma	0.000161	0.000816	CcSEcCtD
Lurasidone—Dermatitis—Dorzolamide—glaucoma	0.000161	0.000815	CcSEcCtD
Lurasidone—Rash—Travoprost—glaucoma	0.000161	0.000812	CcSEcCtD
Lurasidone—Dermatitis—Travoprost—glaucoma	0.00016	0.000812	CcSEcCtD
Lurasidone—Vomiting—Brinzolamide—glaucoma	0.00016	0.000809	CcSEcCtD
Lurasidone—Dizziness—Pilocarpine—glaucoma	0.00016	0.000809	CcSEcCtD
Lurasidone—Nausea—Brimonidine—glaucoma	0.000159	0.000805	CcSEcCtD
Lurasidone—Rash—Brinzolamide—glaucoma	0.000159	0.000802	CcSEcCtD
Lurasidone—Vision blurred—Timolol—glaucoma	0.000159	0.000802	CcSEcCtD
Lurasidone—Dermatitis—Brinzolamide—glaucoma	0.000158	0.000801	CcSEcCtD
Lurasidone—Gastrointestinal pain—Clonidine—glaucoma	0.000158	0.000798	CcSEcCtD
Lurasidone—Hypotension—Betaxolol—glaucoma	0.000157	0.000794	CcSEcCtD
Lurasidone—Angioedema—Timolol—glaucoma	0.000154	0.000778	CcSEcCtD
Lurasidone—Vomiting—Pilocarpine—glaucoma	0.000154	0.000777	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000153	0.000774	CcSEcCtD
Lurasidone—Abdominal pain—Clonidine—glaucoma	0.000153	0.000772	CcSEcCtD
Lurasidone—Rash—Pilocarpine—glaucoma	0.000152	0.000771	CcSEcCtD
Lurasidone—Dermatitis—Pilocarpine—glaucoma	0.000152	0.00077	CcSEcCtD
Lurasidone—Insomnia—Betaxolol—glaucoma	0.000152	0.000769	CcSEcCtD
Lurasidone—Nausea—Dorzolamide—glaucoma	0.000152	0.000769	CcSEcCtD
Lurasidone—Nausea—Travoprost—glaucoma	0.000151	0.000765	CcSEcCtD
Lurasidone—Vertigo—Timolol—glaucoma	0.000151	0.000764	CcSEcCtD
Lurasidone—Syncope—Timolol—glaucoma	0.000151	0.000763	CcSEcCtD
Lurasidone—Dyspnoea—Betaxolol—glaucoma	0.00015	0.000758	CcSEcCtD
Lurasidone—Nausea—Brinzolamide—glaucoma	0.000149	0.000756	CcSEcCtD
Lurasidone—Dyspepsia—Betaxolol—glaucoma	0.000148	0.000748	CcSEcCtD
Lurasidone—Loss of consciousness—Timolol—glaucoma	0.000148	0.000748	CcSEcCtD
Lurasidone—Decreased appetite—Betaxolol—glaucoma	0.000146	0.000739	CcSEcCtD
Lurasidone—Hypertension—Timolol—glaucoma	0.000145	0.000735	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Betaxolol—glaucoma	0.000145	0.000734	CcSEcCtD
Lurasidone—Fatigue—Betaxolol—glaucoma	0.000145	0.000733	CcSEcCtD
Lurasidone—Nausea—Pilocarpine—glaucoma	0.000144	0.000726	CcSEcCtD
Lurasidone—Myalgia—Timolol—glaucoma	0.000143	0.000724	CcSEcCtD
Lurasidone—Anxiety—Timolol—glaucoma	0.000143	0.000722	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000142	0.000719	CcSEcCtD
Lurasidone—Dry mouth—Timolol—glaucoma	0.00014	0.000708	CcSEcCtD
Lurasidone—Asthenia—Clonidine—glaucoma	0.000138	0.000701	CcSEcCtD
Lurasidone—Pruritus—Clonidine—glaucoma	0.000137	0.000691	CcSEcCtD
Lurasidone—Infection—Timolol—glaucoma	0.000136	0.00069	CcSEcCtD
Lurasidone—Shock—Timolol—glaucoma	0.000135	0.000683	CcSEcCtD
Lurasidone—Nervous system disorder—Timolol—glaucoma	0.000135	0.000681	CcSEcCtD
Lurasidone—Skin disorder—Timolol—glaucoma	0.000133	0.000675	CcSEcCtD
Lurasidone—Hyperhidrosis—Timolol—glaucoma	0.000133	0.000671	CcSEcCtD
Lurasidone—Diarrhoea—Clonidine—glaucoma	0.000132	0.000668	CcSEcCtD
Lurasidone—Hypotension—Timolol—glaucoma	0.000128	0.000649	CcSEcCtD
Lurasidone—Dizziness—Clonidine—glaucoma	0.000128	0.000646	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Timolol—glaucoma	0.000125	0.000633	CcSEcCtD
Lurasidone—Insomnia—Timolol—glaucoma	0.000124	0.000628	CcSEcCtD
Lurasidone—Vomiting—Clonidine—glaucoma	0.000123	0.000621	CcSEcCtD
Lurasidone—Dyspnoea—Timolol—glaucoma	0.000122	0.000619	CcSEcCtD
Lurasidone—Somnolence—Timolol—glaucoma	0.000122	0.000617	CcSEcCtD
Lurasidone—Rash—Clonidine—glaucoma	0.000122	0.000616	CcSEcCtD
Lurasidone—Dermatitis—Clonidine—glaucoma	0.000122	0.000615	CcSEcCtD
Lurasidone—Dyspepsia—Timolol—glaucoma	0.000121	0.000611	CcSEcCtD
Lurasidone—Asthenia—Betaxolol—glaucoma	0.000121	0.00061	CcSEcCtD
Lurasidone—Decreased appetite—Timolol—glaucoma	0.000119	0.000604	CcSEcCtD
Lurasidone—Pruritus—Betaxolol—glaucoma	0.000119	0.000601	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Timolol—glaucoma	0.000119	0.0006	CcSEcCtD
Lurasidone—Fatigue—Timolol—glaucoma	0.000118	0.000599	CcSEcCtD
Lurasidone—Diarrhoea—Betaxolol—glaucoma	0.000115	0.000582	CcSEcCtD
Lurasidone—Nausea—Clonidine—glaucoma	0.000115	0.00058	CcSEcCtD
Lurasidone—Gastrointestinal pain—Timolol—glaucoma	0.000112	0.000568	CcSEcCtD
Lurasidone—Dizziness—Betaxolol—glaucoma	0.000111	0.000562	CcSEcCtD
Lurasidone—Abdominal pain—Timolol—glaucoma	0.000109	0.000549	CcSEcCtD
Lurasidone—Vomiting—Betaxolol—glaucoma	0.000107	0.00054	CcSEcCtD
Lurasidone—Rash—Betaxolol—glaucoma	0.000106	0.000536	CcSEcCtD
Lurasidone—Dermatitis—Betaxolol—glaucoma	0.000106	0.000535	CcSEcCtD
Lurasidone—Nausea—Betaxolol—glaucoma	9.98e-05	0.000505	CcSEcCtD
Lurasidone—Asthenia—Timolol—glaucoma	9.85e-05	0.000498	CcSEcCtD
Lurasidone—Pruritus—Timolol—glaucoma	9.71e-05	0.000491	CcSEcCtD
Lurasidone—Diarrhoea—Timolol—glaucoma	9.39e-05	0.000475	CcSEcCtD
Lurasidone—Dizziness—Timolol—glaucoma	9.08e-05	0.000459	CcSEcCtD
Lurasidone—Vomiting—Timolol—glaucoma	8.73e-05	0.000442	CcSEcCtD
Lurasidone—Rash—Timolol—glaucoma	8.66e-05	0.000438	CcSEcCtD
Lurasidone—Dermatitis—Timolol—glaucoma	8.65e-05	0.000437	CcSEcCtD
Lurasidone—Nausea—Timolol—glaucoma	8.15e-05	0.000412	CcSEcCtD
Lurasidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.08e-05	0.00175	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.06e-05	0.00174	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CA1—glaucoma	2.04e-05	0.00172	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CTSA—glaucoma	1.98e-05	0.00167	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—SMO—glaucoma	1.97e-05	0.00166	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	1.96e-05	0.00165	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.93e-05	0.00163	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—TGFB2—glaucoma	1.91e-05	0.00161	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—OPN4—glaucoma	1.9e-05	0.0016	CbGpPWpGaD
Lurasidone—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.89e-05	0.00159	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.89e-05	0.00159	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—EDN1—glaucoma	1.87e-05	0.00158	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CA2—glaucoma	1.87e-05	0.00157	CbGpPWpGaD
Lurasidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.86e-05	0.00156	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—OPN4—glaucoma	1.84e-05	0.00155	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—EDN1—glaucoma	1.81e-05	0.00153	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—RPTOR—glaucoma	1.8e-05	0.00152	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—SOD1—glaucoma	1.79e-05	0.00151	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HEYL—glaucoma	1.76e-05	0.00149	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NCK2—glaucoma	1.75e-05	0.00147	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PTGFR—glaucoma	1.71e-05	0.00144	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HEYL—glaucoma	1.71e-05	0.00144	CbGpPWpGaD
Lurasidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.69e-05	0.00142	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—OPN4—glaucoma	1.67e-05	0.0014	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CA1—glaucoma	1.66e-05	0.0014	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PTGFR—glaucoma	1.65e-05	0.00139	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—EDN1—glaucoma	1.65e-05	0.00139	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.64e-05	0.00139	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—OPN4—glaucoma	1.64e-05	0.00138	CbGpPWpGaD
Lurasidone—HTR1A—GPCR ligand binding—C3—glaucoma	1.64e-05	0.00138	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.63e-05	0.00137	CbGpPWpGaD
Lurasidone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.62e-05	0.00137	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—EDN1—glaucoma	1.62e-05	0.00136	CbGpPWpGaD
Lurasidone—HTR1A—SIDS Susceptibility Pathways—TNF—glaucoma	1.62e-05	0.00136	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CTSA—glaucoma	1.61e-05	0.00135	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR ligand binding—C3—glaucoma	1.58e-05	0.00133	CbGpPWpGaD
Lurasidone—HTR7—Circadian rythm related genes—TP53—glaucoma	1.57e-05	0.00132	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HEYL—glaucoma	1.55e-05	0.00131	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HEYL—glaucoma	1.52e-05	0.00128	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CA2—glaucoma	1.52e-05	0.00128	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PTGFR—glaucoma	1.5e-05	0.00126	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—OPN4—glaucoma	1.49e-05	0.00126	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HDAC9—glaucoma	1.49e-05	0.00125	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PTGFR—glaucoma	1.48e-05	0.00124	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—EDN1—glaucoma	1.47e-05	0.00124	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—SMO—glaucoma	1.46e-05	0.00123	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—SOD1—glaucoma	1.45e-05	0.00122	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CA5A—glaucoma	1.45e-05	0.00122	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NARFL—glaucoma	1.45e-05	0.00122	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—C3—glaucoma	1.44e-05	0.00121	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—EDN1—glaucoma	1.43e-05	0.0012	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—C3—glaucoma	1.41e-05	0.00119	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—SMO—glaucoma	1.41e-05	0.00119	CbGpPWpGaD
Lurasidone—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	1.4e-05	0.00118	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HEYL—glaucoma	1.39e-05	0.00117	CbGpPWpGaD
Lurasidone—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.38e-05	0.00116	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—MMP1—glaucoma	1.36e-05	0.00115	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PTGFR—glaucoma	1.34e-05	0.00113	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RPTOR—glaucoma	1.34e-05	0.00113	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—TXN—glaucoma	1.32e-05	0.00111	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.31e-05	0.00111	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—CAV1—glaucoma	1.31e-05	0.0011	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—EDN1—glaucoma	1.3e-05	0.00109	CbGpPWpGaD
Lurasidone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.3e-05	0.00109	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NCK2—glaucoma	1.29e-05	0.00109	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RPTOR—glaucoma	1.29e-05	0.00109	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—C3—glaucoma	1.29e-05	0.00108	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—SMO—glaucoma	1.28e-05	0.00108	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—SMO—glaucoma	1.26e-05	0.00106	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NCK2—glaucoma	1.25e-05	0.00106	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—C3—glaucoma	1.25e-05	0.00105	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—FN1—glaucoma	1.24e-05	0.00105	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RPTOR—glaucoma	1.17e-05	0.000989	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—SMO—glaucoma	1.16e-05	0.00098	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RPTOR—glaucoma	1.16e-05	0.000973	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—SMO—glaucoma	1.15e-05	0.000966	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NCK2—glaucoma	1.14e-05	0.000958	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—C3—glaucoma	1.13e-05	0.000955	CbGpPWpGaD
Lurasidone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.12e-05	0.000945	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NCK2—glaucoma	1.12e-05	0.000943	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—MMP1—glaucoma	1.11e-05	0.000933	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HDAC9—glaucoma	1.1e-05	0.000928	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TXN—glaucoma	1.07e-05	0.0009	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HDAC9—glaucoma	1.07e-05	0.000898	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NTRK2—glaucoma	1.06e-05	0.000896	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—CAV1—glaucoma	1.06e-05	0.000894	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—EDN1—glaucoma	1.06e-05	0.000892	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.05e-05	0.000885	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—EDN1—glaucoma	1.02e-05	0.000863	CbGpPWpGaD
Lurasidone—DRD2—Circadian rythm related genes—TP53—glaucoma	1.02e-05	0.00086	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GSTT1—glaucoma	1.02e-05	0.00086	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NCK2—glaucoma	1.02e-05	0.000858	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—FN1—glaucoma	1.01e-05	0.000851	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—NOS3—glaucoma	9.88e-06	0.000832	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HDAC9—glaucoma	9.67e-06	0.000815	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—EDN1—glaucoma	9.62e-06	0.00081	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HDAC9—glaucoma	9.51e-06	0.000801	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—EDN1—glaucoma	9.3e-06	0.000784	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—EDN1—glaucoma	9.3e-06	0.000783	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—C3—glaucoma	9.25e-06	0.000779	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—EDN1—glaucoma	9.15e-06	0.000771	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NGFR—glaucoma	9.12e-06	0.000769	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—C3—glaucoma	8.95e-06	0.000754	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NTRK1—glaucoma	8.67e-06	0.00073	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HDAC9—glaucoma	8.65e-06	0.000729	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SMO—glaucoma	8.62e-06	0.000726	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—EDN1—glaucoma	8.44e-06	0.000711	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—C3—glaucoma	8.4e-06	0.000708	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SMO—glaucoma	8.34e-06	0.000702	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	8.32e-06	0.000701	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—EDN1—glaucoma	8.31e-06	0.0007	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GSTT1—glaucoma	8.29e-06	0.000698	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—C3—glaucoma	8.13e-06	0.000685	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CYP1B1—glaucoma	8.13e-06	0.000685	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ABCA1—glaucoma	8.13e-06	0.000685	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—C3—glaucoma	8.12e-06	0.000684	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—NOS3—glaucoma	8.02e-06	0.000676	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—C3—glaucoma	7.99e-06	0.000673	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CDKN2B—glaucoma	7.99e-06	0.000673	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NTRK2—glaucoma	7.88e-06	0.000664	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—EDN1—glaucoma	7.66e-06	0.000646	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NTRK2—glaucoma	7.62e-06	0.000642	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SMO—glaucoma	7.56e-06	0.000637	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—EDN1—glaucoma	7.56e-06	0.000637	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SMO—glaucoma	7.44e-06	0.000627	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—C3—glaucoma	7.37e-06	0.000621	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—C3—glaucoma	7.27e-06	0.000613	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—C3—glaucoma	7.26e-06	0.000611	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—VEGFA—glaucoma	7.12e-06	0.0006	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CA1—glaucoma	7.06e-06	0.000595	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NGF—glaucoma	7.04e-06	0.000594	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NTRK2—glaucoma	6.92e-06	0.000583	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CTSA—glaucoma	6.84e-06	0.000577	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NTRK2—glaucoma	6.81e-06	0.000574	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SMO—glaucoma	6.77e-06	0.000571	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGFR—glaucoma	6.76e-06	0.00057	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—C3—glaucoma	6.7e-06	0.000564	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—C3—glaucoma	6.6e-06	0.000556	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CYP1B1—glaucoma	6.6e-06	0.000556	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ABCA1—glaucoma	6.6e-06	0.000556	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGFR—glaucoma	6.54e-06	0.000551	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—GSTM1—glaucoma	6.5e-06	0.000547	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CA2—glaucoma	6.46e-06	0.000544	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NTRK1—glaucoma	6.42e-06	0.000541	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—APOE—glaucoma	6.23e-06	0.000525	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NTRK1—glaucoma	6.22e-06	0.000524	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NTRK2—glaucoma	6.19e-06	0.000522	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CAV1—glaucoma	6.18e-06	0.00052	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGFR—glaucoma	5.94e-06	0.0005	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CDKN2B—glaucoma	5.92e-06	0.000499	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—FN1—glaucoma	5.88e-06	0.000495	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGFR—glaucoma	5.84e-06	0.000492	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—BAD—glaucoma	5.81e-06	0.000489	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—VEGFA—glaucoma	5.78e-06	0.000487	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MTHFR—glaucoma	5.74e-06	0.000484	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	5.73e-06	0.000483	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—EDN1—glaucoma	5.68e-06	0.000479	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NTRK1—glaucoma	5.64e-06	0.000475	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NTRK1—glaucoma	5.55e-06	0.000468	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—EDN1—glaucoma	5.5e-06	0.000463	CbGpPWpGaD
Lurasidone—ADRA2C—Hemostasis—TP53—glaucoma	5.38e-06	0.000453	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—APOE—glaucoma	5.35e-06	0.00045	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGFR—glaucoma	5.31e-06	0.000448	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CAV1—glaucoma	5.3e-06	0.000446	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—GSTM1—glaucoma	5.28e-06	0.000445	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NGF—glaucoma	5.22e-06	0.00044	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CDKN2B—glaucoma	5.2e-06	0.000438	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CDKN2B—glaucoma	5.11e-06	0.000431	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NGF—glaucoma	5.05e-06	0.000426	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NTRK1—glaucoma	5.05e-06	0.000425	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—EDN1—glaucoma	4.99e-06	0.00042	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—C3—glaucoma	4.96e-06	0.000418	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—EDN1—glaucoma	4.91e-06	0.000413	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—C3—glaucoma	4.8e-06	0.000405	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NOS3—glaucoma	4.67e-06	0.000394	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTHFR—glaucoma	4.66e-06	0.000393	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	4.65e-06	0.000392	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—APOE—glaucoma	4.62e-06	0.000389	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NGF—glaucoma	4.58e-06	0.000386	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CAV1—glaucoma	4.58e-06	0.000386	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TXN—glaucoma	4.55e-06	0.000384	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NGF—glaucoma	4.51e-06	0.00038	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—APOE—glaucoma	4.47e-06	0.000377	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—EDN1—glaucoma	4.46e-06	0.000376	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CAV1—glaucoma	4.43e-06	0.000373	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—TP53—glaucoma	4.37e-06	0.000368	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—C3—glaucoma	4.36e-06	0.000367	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—FN1—glaucoma	4.36e-06	0.000367	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—APOE—glaucoma	4.34e-06	0.000366	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—BAD—glaucoma	4.3e-06	0.000363	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CAV1—glaucoma	4.3e-06	0.000363	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—C3—glaucoma	4.29e-06	0.000361	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—FN1—glaucoma	4.22e-06	0.000355	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—BAD—glaucoma	4.17e-06	0.000351	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NGF—glaucoma	4.1e-06	0.000346	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—glaucoma	4.06e-06	0.000342	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—CDKN1B—glaucoma	4.05e-06	0.000341	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CAV1—glaucoma	4.02e-06	0.000339	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NOS3—glaucoma	4e-06	0.000337	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—glaucoma	3.99e-06	0.000336	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CAV1—glaucoma	3.95e-06	0.000333	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—C3—glaucoma	3.9e-06	0.000329	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—FN1—glaucoma	3.82e-06	0.000322	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—BAD—glaucoma	3.78e-06	0.000318	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—FN1—glaucoma	3.76e-06	0.000317	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—glaucoma	3.75e-06	0.000316	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—BAD—glaucoma	3.72e-06	0.000313	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—glaucoma	3.66e-06	0.000309	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—glaucoma	3.63e-06	0.000306	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CAV1—glaucoma	3.6e-06	0.000303	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTT1—glaucoma	3.53e-06	0.000297	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—glaucoma	3.46e-06	0.000292	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—FN1—glaucoma	3.42e-06	0.000289	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—BAD—glaucoma	3.38e-06	0.000285	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—VEGFA—glaucoma	3.36e-06	0.000284	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—glaucoma	3.35e-06	0.000282	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—glaucoma	3.25e-06	0.000274	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—glaucoma	3.04e-06	0.000256	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CDKN1B—glaucoma	3e-06	0.000253	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—glaucoma	2.99e-06	0.000252	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—glaucoma	2.98e-06	0.000251	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	2.9e-06	0.000244	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP1B1—glaucoma	2.81e-06	0.000237	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ABCA1—glaucoma	2.81e-06	0.000237	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—glaucoma	2.78e-06	0.000234	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.72e-06	0.000229	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—glaucoma	2.69e-06	0.000226	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.63e-06	0.000222	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.59e-06	0.000218	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TP53—glaucoma	2.54e-06	0.000214	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.49e-06	0.00021	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—glaucoma	2.44e-06	0.000205	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.41e-06	0.000203	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—glaucoma	2.4e-06	0.000202	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.36e-06	0.000199	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GSTM1—glaucoma	2.25e-06	0.000189	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—VEGFA—glaucoma	2.19e-06	0.000184	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.18e-06	0.000184	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.15e-06	0.000182	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—glaucoma	1.99e-06	0.000167	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.96e-06	0.000165	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TP53—glaucoma	1.88e-06	0.000159	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—glaucoma	1.85e-06	0.000156	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAV1—glaucoma	1.83e-06	0.000154	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TP53—glaucoma	1.82e-06	0.000154	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TP53—glaucoma	1.65e-06	0.000139	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TP53—glaucoma	1.63e-06	0.000137	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TP53—glaucoma	1.48e-06	0.000125	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—glaucoma	1.39e-06	0.000117	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—glaucoma	1.27e-06	0.000107	CbGpPWpGaD
